key: cord-0864610-tk4e7znm authors: Li, Youjiang; Hu, Yingying; Yu, Yuanyuan; Zhang, Xiaodong; Li, Bin; Wu, Jianguo; Li, Junyu; Wu, Yingping; Xia, Xiaoping; Tang, Huina; Xu, Jian title: Positive result of Sars‐Cov‐2 in faeces and sputum from discharged patient with COVID‐19 in Yiwu, China date: 2020-04-20 journal: J Med Virol DOI: 10.1002/jmv.25905 sha: addb074446a63844092659ec9991771d37b09a38 doc_id: 864610 cord_uid: tk4e7znm BACKGROUND: With the effective prevention and control of COVID ‐ 19 in China, the number of cured cases increased significantly. Further monitoring of the disease prognosis and effective control of the "relapse" of the epidemic become the next focus of work. To analyse the clinical prognosis of discharged COVID‐19 patients by monitoring their SAR‐CoV‐2 nucleic acid status, which may provide evidence to establish discharge standards and follow‐up management for COVID‐19 patients. METHODS: We included 13 discharged COVID‐19 patients who were quarantined for 4‐week at home. The patient's daily clinical signs were recorded and sputum and faecal specimens were regularly sent for the detection of SARS‐CoV‐2 nucleic acid. RESULTS: The time between initial symptoms and meeting discharge criteria was 18 – 44 days with an average of 25 ± 6 days. The faecal samples of two patients still tested positive after meeting discharge criteria and the sputum samples of four patients returned positive 5 – 14 days after discharge. The rate of a recurring positive test result in samples from the respiratory system was 31%(4/13). CONCLUSION: Under the present discharge criteria, the high presence of SARS‐CoV‐2 nucleic acid in faecal and respiratory samples of discharged COVID‐19 patients indicate potential infectivity. Therefore, we suggest that faecal virus nucleic acid should be tested as a routine monitoring index for COVID‐19 and a negative result be added to the criteria. Simultaneously, we should strengthen the regular follow‐up of discharged patients with continuous monitoring of the recurrence of viral nucleic acid. This article is protected by copyright. All rights reserved. In December 2019, a novel coronavirus caused an outbreak in Wuhan, China. 1, 2 The WHO declared the novel coronavirus pneumonia outbreak to be a This article is protected by copyright. All rights reserved. Public Health Emergency of International Concern (PHEIC) on 30 January 2020 and a global pandemic on 11 March 2020. 3 Accepted Article version 5)". 6 The aim of this study is to analyse the causes of viral nucleic acid reemergence by investigating the follow-up data of COVID-19 patients who met the discharge criteria. This may provide evidence that medical institutions should strengthen the follow-up management of discharged COVID-19 patients. We recruited 13 patients who were diagnosed as COVID-19 at the Fourth Affiliated Hospital of Zhejiang University from Jan. 26, 2020 to Feb. 6, 2020. All patients with COVID-19 were tested positively for SARS-CoV-2 by use of quantitative RT-PCR on samples from the respiratory tract. All cases had met the latest discharge criteria or COVID-19 patients from Feb. 9, 2020 to Feb. 28, 2020. This article is protected by copyright. All rights reserved. Oral swabs, nasal swabs, sputum, blood, faeces, urine, vaginal secretions and milk of COVID-19 patients were collected for viral nucleic acid test upon hospitalisation. After COVID-19-confirmed patients met the discharge criteria, they should: (1) Be quarantined for 4 weeks at Home (2) wear medical masks when leaving home and keep distance with others to reduce contact (3) Attend follow-up visit in the first, second, and fourth week after discharge with sputum and faecal viral nucleic acid tests, routine blood examination, biochemistry tests including Creactive protein, and lung CT scan. (4) monitor body temperature and other symptoms daily during isolation. If any symptoms such as fever, cough, sore throat, fatigue, and muscle soreness were found, patients should immediately return to the hospital to determine respiratory and faecal virus nucleic acid status. SARS-CoV-2 nucleic acid was detected by real-time reverse transcription polymerase chain reaction (RT-PCR). The nucleic acid RT-PCR test kit we employed was recommended by the Chinese Center for Disease Control and Prevention (China CDC) and produced by Shanghai Zhijiang Biotechnology, China. Nucleic acid was extracted from the samples using an EX2400 Automatic Nucleic Acid Extractor (Shanghai Zhijiang Biotechnology, China). RT-PCR was performed in a LightCycler 480 Instrument II (Roche, Germany). We quantified the RdRP, E, and N gene in the SARS-CoV-2 genome and used the criterion as described by the manufacturer to determine positivity. Specimen collection, treatment, and laboratory procedures were in strict accordance with the operating procedures recommended by WHO for RT-PCR and we performed clinical resampling if results were unclear. Baseline information, laboratory and imaging examinations, diagnosis, and treatment process of the included cases were obtained from the electronic medical record system. All information was obtained and curated with a standardised data collection form. Two researchers independently reviewed the data collection forms. Statistical analysis was performed using SPSS 20.0. Continuous variables were summarised as means and standard deviations or medians and interquartile ranges (IQR) as appropriate. Categorical variables were expressed as counts and percentages in each category. For laboratory results, we also assessed whether the measurements were outside the normal range. We included 13 patients confirmed with COVID-19, six males and seven females with an average age of 52.8 ± 20.2 years. The time from onset of symptoms Accepted Article to the diagnosis of the COVID-19 patients was 1-19 days and discharge criteria were met between 9 to 28 February 2020. The time from initial onset of symptoms to meeting the discharge criteria was 18-44 days with a median time of 25 ± 6 days. According to the epidemiological history of the patients, four were long-term residents of Wuhan returning to Yiwu, nine had direct contact with people returned from Wuhan. All patients presented with the common main symptoms of fever, cough, fatigue, muscle soreness, and sore throat. The laboratory parameters showed that ten cases had a low to normal white blood cell count, five cases had lymphocytopenia, and only two cases presented with elevated C-reactive protein while all 13 cases had normal transaminase levels. The CT examination indicated the typical features of viral pneumonia such as a patchy ground glass opacity. The main therapies were antiviral, antibiotic, and oxygen inhalation without additional glucocorticoids treatment. (Table 1 ) We tested each type of specimens more than 3 times for SARS-CoV-2 nucleic acid upon hospitalisation. Test results showed that the positive rate in sputum was 100% (13/13), oral swab was 40% (4/10), nose swab was 75% (9/12), and faeces was 38% (5/13). Concurrently, the urine and blood viral nucleic acid of all 13 patients tested negative. Similarly, the vaginal secretions of the six female patients This article is protected by copyright. All rights reserved. tested negative and the milk of one lactating patient was also negative ( Table 2 and Figure 1 ). In subsequent monitoring of viral nucleic acid status of discharged patient, faeces from 2 patients(patient 5 and 13) continuously tested positive for SARS-CoV-2 even though sputum was negative. Faeces from patient 5 tested positive for 14 days and patient 5 for 15 days after sputum was negative. (Figure 2 ). By 28 March 2020, all discharged patients were followed up for 4 weeks. Four discharged patients(Patient 2,3,8,9) presented a positive sputum viral nucleic acid test during a later follow-up between 5 -14 days after discharge. In particular, patient 8 who had a recurrence of viral nucleic acid five days after discharge was able to meet discharge criteria again, after which the patient once more tested positive seven days after the second discharge ( Figure 3 ). And patient 2 had a complication of chronic lymphocytic leukemia (Table 1) . Although we detected SARS-CoV-2 nucleic acid in these patients after discharge, the blood examination, C-reactive protein levels, biochemistry, and lung CT showed no obvious abnormalities and no clinical symptoms were observed. (Figure 4 and This article is protected by copyright. All rights reserved. Currently, the recognised transmission route of COVID-19 is mainly through respiratory droplets and close contact. The patient's infectivity is determined by the presence of the virus in different body fluids, secretions, and excrements. It has been confirmed that viral nucleic acid can be detected in samples of oral swabs, sputum, faeces, urine, and tears of COVID-19 patients. 7, 8 In this study, 5 of the 13 patients (38%) were tested positive for faecal nucleic acid, which was higher than previously reported .9,10 Blood and urine samples of all patients were negative for SARS-CoV-2 nucleic acid, possibly because we included relatively few cases in this study and all of them were mild cases with common symptoms. The results of viral nucleic acid tests in the vaginal secretions of six female patients and the milk of one lactating patient were negative, consistent with previous studies. 11 Similar to other reports, we found that the positive rate of viral nucleic acid test in respiratory tract specimens was highest in the sputum, followed by nasal swab and oral swab. 12 It is suggested that sputum collection should be given priority when collecting respiratory tract specimens of COVID-19 patients for viral nucleic acid testing. In the absence of sputum, nasal swab may be more sensitive than oral swab for the detection of SARS-CoV-2 nucleic acid. In our study, two patients continued to test positive for SARS-CoV-2 nucleic acid in faeces for up to 15 days after the negative results from respiratory tissues. This article is protected by copyright. All rights reserved. Zhang et al. reported that three children with COVID-19 were discharged from hospital with negative respiratory virus, and were re-examined positive nucleic acid from feaces within 10 days. 13 15 Previous studies have confirmed that SARS-CoV-2 enters and infects host cells through the cell receptor angiotensin-converting enzyme 2 (ACE2). 16 Zhang et al. found that ACE2 was highly expressed not only in alveolar epithelial cells, but also in oesophageal and lamellar epithelial cells as well as in epithelial cells in the ileum and colon. 17 The above data suggest that SARS-CoV-2 may invade the digestive tract via ACE2 receptors, leading to gastrointestinal symptoms. Nouri-vaskeh M et al. speculated the existence of fecal-oral transmission of SARS-CoV-2 by referring to published articles. 18 Taken together, this highly suggests that faecal-oral transmission may be another potential route for SARS-CoV-2. During the SARS epidemic in Hong Kong, China, there was a large-scale community infection caused by the excrement of patients. A SARS patient with diarrhea visited a relative's home in a residential area and used the toilet twice.In the end, 321 people were infected and 42 died because of a flaw in the building's sewage system design. 19 Therefore, based on the SARS prevention and control experience, This article is protected by copyright. All rights reserved. we need to be cautious in discharging patients whose respiratory samples test negative for viral nucleic acid test but continue to show positivity in faeces, even though they have met the discharge criteria of the national "Diagnosis and Treatment Scheme of COVID-19", and protective measures will need to be enhanced to prevent faecal-oral transmission. The author suggested that faecal virus nucleic acid should be tested as a routine monitoring index in the daily diagnosis and follow-up of COVID-19 patients, and whether to increase the faecal nucleic acid test negative for two consecutive times in the discharge criteria. Recurrence of viral nucleic acid in sputum was shown in 4 of the 13 discharged This article is protected by copyright. All rights reserved. There may be three possibilities for the recurrence of viral nucleic acid in discharged patients. One possibility is that the test results before discharge were false negative due to a flawed sample. It has been reported that the detection rate of viral nucleic acid in oral swabs is only 30% ~ 50% and is higher in nasal swabs. In comparison, the detection rate in sputum is higher than that of both nasal and oral swabs. 12 False negative results caused by improper sampling could be effectively reduced by collecting deep sputum and alveolar lavage fluid, increasing faecal examinations, and repeated testing of (suspected) patients. The second possibility is that the virus in the patient was not completely cleared, but the viral load was below the detection limit of the assay, resulting in the false negative results. With changes in the immune system of the host, the virus may re-emerge and increase the viral load above the detection limit. Finally, cured patients may have developed a secondary infection with SARS-CoV-2 due to re-exposure to the virus. In our study, all four discharged patients had negative sputum(not pharyngeal swab) results in 4-5 consecutive viral nucleic acid tests with at least one day between each test prior to recurrence of the virus. This indicates that the results were unlikely to be false negative due to improper sampling. In an earlier study of COVID-19, virus-specific IgM and IgG antibody was detected in 50% (8/16) and 81% (13/16) of the patients' serum, respectively, after 10 days of treatment. On day 15 after treatment, the presence of virus-specific IgM and IgG was as high as 81% (13/16) and 100% (16/16), respectively, indicating that patients with COVID-19 generally This article is protected by copyright. All rights reserved. produce protective antibodies in the early stage of disease. 8 showed that in SARS patients, specific IgG antibodies can persist for 12 years. 22 These studies suggest that patients infected with SARS-CoV-2 carry protective antibodies after recovery and may be able to maintain immunity for a long time. And the four patients were kept in strict isolation at home after discharge, with no history of re-epidemiological exposure. Therefore, the possibility of re-infection in a short time is very small. Simultaneously, we did not observe any clinical symptoms related to viral pneumonia during the follow-up in the four patients with recurring viral nucleic acid and no progression of the disease was found in CT scans of the lungs, which indicated that the patients were not cases of recurrence of the disease but rather an asymptomatic virus carrier. SARS-CoV-2 has a strong transmission capability and a fast infection rate. The elderly and those with chronic underlying diseases have a poor prognosis. 23 At present, the sources of infection are COVID-19 patients and asymptomatic virus carriers may also spread the virus. The results of this study indicated that under the current discharge criteria, there may be a large proportion of discharged patients who are still virus carriers. To determine whether these viral nucleic acid relapsing patients are infectious, we need to consider two factors. One is to clarify the relationship between the chance of viral transmission and viral load in patients. We can then determine the viral load in relapsing patients to assess their infectiousness. Second, it is necessary to distinguish whether the viral nucleic acid positivity of This article is protected by copyright. All rights reserved. Accepted Article discharged patients is due to residual virus or active replication. Currently, these factors remain to be elucidated. Therefore, without clear evidence that discharged patients are not infectious, the patients themselves and others will be at great risk if they are not adequately followed-up and strictly isolated after discharge. In view of the current discharge criteria, the presence of viral nucleic acid in the faeces and the rate of recurrence in sputum of discharged patients have led us to propose the following suggestions. First, it may be necessary to reassess the suitability of the current discharge criteria which requires two consecutive days of negative viral nucleic acid testing in respiratory samples at least one day apart. 1 Female 24 + -+ ----NT 2 Female 72 + -+ ----NT 3 Female 71 + NT + -+ --NT 4 Female 56 + -----NT NT 5 Female 33 + -+ -+ --NT 6 Female 37 + ------NT 7 Female 33 + + + -----8 Male 37 + + + ---NT NT 9 Male 73 + NT ----NT NT 10 Male 47 + -+ ---NT NT + NT NT -+ -NT NT 12 Male 70 + + + -+ -NT NT 13 Male 22 + + + -+ -NT Annotation: "+"=Positive,"-"=Negative,OS=Oral swab,NS=Nasal swab,VS=Vaginal secretion,BM=Breast milk; NT=Do not detect. Clinical features of patients infected with 2019novel coronavirus in Wuhan World Health Organization.Novel oronavirus-China World Health Organization. Corona virus disease (COVID-19) outbreak Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Accepted Article 6. National health commission of the People's Republic of China. Diagnosis and Treatment Scheme of Novel Coronavirus Infected Pneumonia (trial version 5 Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Detectable SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period of COVID-19 Pneumonia Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China The Presence of SARS-CoV-2 RNA in Feces Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes Fecal transmission in COVID-19: A potential shedding route Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Positive RT-PCR Test Results in Patients Recovered From COVID-19 The 31st press conference on epidemic prevention and control from Guangdong Provincial Government Information Office Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province This study was supported by Zhejiang University special scientific research fund for COVID-19 prevention and control(2020XGZX064), Jin hua Science and Lymphopenia (<1.5×10 9 /L)